Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PLSE
PULSE BIOSCIENCES, INC.
NASDAQ
$50.42
▲ UP 5.37% (2.57)

KEY STATISTICS

Market Cap$3.49 B
52w High$50.71
52w Low$12.56
Dividend Yield—
Frequency—
P/E-42.73
Volume453.13K
Shares Out.69.21M

COMPANY

LEADERSHIP

Paul Arthur LaViolette
CHIEF EXECUTIVE
Paul Arthur LaViolette

COMPENSATION 2026

Salary$708,523
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$1,416
Total$7,427,899

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 18, 2016
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
116

PRICE TARGET

Target High$58.00
Target Low$35.00
Target Median$44.00
Target Consensus$45.25

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$625.00K
NOV
4
WED

PRICE

$50.42 ▲ UP 5.37% (+$2.57)
$48.00$49.00$50.009:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM50.42

About Pulse Biosciences, Inc.

https://www.pulsebiosciences.com ↗

Pulse Biosciences, Inc. develops the CellFX System, a nano-pulse electrical platform using Nano-Pulse Stimulation technology to selectively treat medical conditions by targeting cells without harming surrounding tissue.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT PULSE BIOSCIENCES, INC. IS KNOWN FOR

nPulse Vybrance Percutaneous Ablation System
nPulse Vybrance Percutaneous Ablation System

The nPulse Vybrance system by Pulse Biosciences uses Nanosecond Pulsed Field Ablation to minimally invasively treat benign thyroid nodules and is under investigation for thyroid cancer therapy.

COMPETITORS

COMPETITOR
ABT COMPARE
ATRC COMPARE
BSX COMPARE
JNJ COMPARE
MDT COMPARE

Revenue by Products

IconPRODUCTQ3-2021Q3-2025
Systems Products$490K —
Operating Segments— $172K
Cycle Units Products$84K —

Revenue by Geography

MapREGIONQ3-2021
North America$405K
NonUS$169K

ETFS HOLDING THIS STOCK

ETFS HOLDING
83
LISTED HERE
13
RANKED BY POSITION SIZE
VTS.AX
0.00% · 554.6K
IWM
0.03% · 479.7K
SCHA
0.02% · 90.0K
XHE
1.51% · 55.5K
ISMD
0.32% · 24.2K
ONEQ
0.01% · 23.9K
XRS2.DE
0.03% · 16.1K
RSSL
0.03% · 8.8K
ESSC
0.16% · 1.6K
URTY
0.01% · 753
TNXT
0.17% · 661
USUE.DE
0.00% · 92
RTYS.L
0.03% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
10.88%
HOLDERS
131
TOP 12 OF 131 · RANKED BY POSITION SIZE
Blackrock, Inc.
1.4M sh · $18.63M
Blackrock Inc.
1.1M sh · $12.83M
Vanguard Group Inc
1.1M sh · $15.36M
Bank Of America Corp /De/
866.1K sh · $18.7M
Portolan Capital Management, LLC
733.4K sh · $15.83M
Geode Capital Management, LLC
491.9K sh · $10.62M
Massachusetts Financial Services Co /Ma/
462.9K sh · $9.99M
State Street Corp
456.9K sh · $9.87M
Balyasny Asset Management L.P.
265.2K sh · $5.72M
Griffin Asset Management, Inc.
227.3K sh · $4.02M
Lmr Partners Llp
213.1K sh · $4.6M
Northern Trust Corp
192.6K sh · $3.41M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
van den Broek Richard
Purchase · 30.0K shares
2026-06-11
★
DIRECTOR
van den Broek Richard
Purchase · 8.4K shares
2026-06-11
★
DIRECTOR, 10 PERCENT OWNER:
DUGGAN ROBERT W
Purchase · 30.0K shares
2026-06-11
★
DIRECTOR, 10 PERCENT OWNER:
DUGGAN ROBERT W
Purchase · 12.5K shares
2026-06-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY

SECTORS PEERS

PEERPRICE
DNTH$111.10COMPARE
ATAI$7.38COMPARE
NKTR$74.02COMPARE
NVCR$17.10COMPARE
KMTS$26.99COMPARE
IMTX$8.93COMPARE
STAA$23.14COMPARE
OPK$1.48COMPARE